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Abstract: 
The Quantitative Structure Activity Relationship (QSAR) study is performed over a set of 15, 4-alkyl/aryl-substituted 1-
[benzofuran-2-yl-phenylmethyl]-1 H-triazoles derivatives. This study is based on the application of physicochemical parameters in 
QSAR. The parameters include (MR (molar refractivity), MW (molecular weight), Pc (parachor), St (surface tension), D (density), Ir 
(index of refraction) and log P (partition coefficient). The parameters describing physiochemical properties are used as independent 
variables and the biological activity (IC50) is considered as dependent variable in multiple regression analysis. Different models 
were generated with high co-efficient of determination (R2). The 2D-QSAR study identified compounds capable of inhibiting the 
metabolic breakdown of the retinoid (trans-retinoic acid (ATRA)) involved in the activation of specific nuclear Retinoic acid 
receptors (RARs). This study identifies R115866 as a potential inhibitor of the cytochrome P450 (CYP) mediated metabolism with 
increased RA levels for retinoid actions.  
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Background: 
In human, CYP26A1 mapped to chromosomes 10q23-q24 is 
expressed in the liver, heart, pituitary gland, adrenal gland, 
testis, brain and placenta. It is thought that the principle role of 
CYP26A1 is homeostatic for the regulation of intercellular 
ATRA (Anti Trans Retinoic Acid) steady state levels via a 
negative feedback loop (similar to CYP26A1 cholecalciferol 
metabolism). The enzyme is an important regulator of 
differentiation and a possible modulator of disease states in 
indirectly controlling ATRA and other retinoid concentrations. 
 
Retinoic acid has been used in a number of clinical situations, 
especially oncology and dermatology. In Oncology ATRA has 
shown spectacular success in the treatment of acute 
promyelocytic leukaemia. Although other CYPs are also 
induced by ATRA, it is thought that CYP26A1 is likely to be the 
most important enzyme involved in its degradation [1]. ATRA 
regulates epithelial differentiation and growth through 
activation of specific nuclear retinoic acid receptors (RARs). We 
identified compounds capable of inhibiting the metabolic 
breakdown of the retinoid because high rate metabolism largely 
impairs the biological efficiency of RA.  
 
QSAR studies are of importance in molecular biochemistry. It is 
essential that appropriate descriptors are employed, whether 
they are theoretical, empirical or derived from available 
experimental characteristics of structure to obtain significant 
correlation.  QSAR represents an attempt to correlate structural 
or property descriptors of compound with activities. These 
physiochemical descriptors include parameters to account for 
hydrophobicity, topology, electronic parameters and steric 
effects. These are determined empirically by computational 
methods. Quantitative Structure Activity Relationship (QSAR) 
is currently being applied in many disciplines pertaining to 
drug design and environmental risk assessments [2].  
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An insight to structure activity relationship is established using 
molecular descriptors that effectively characterize molecular 
size, molecular branching or the variations in molecular shapes 
affecting the structure and its molecular activity. Structural 
invariants derived from molecular structure are important for 
the understanding of a particular structure/property activity 
relationship. Several graph theoretical invariants have been 
generalized to produce structure dependent descriptors. It 
should be noted that most biological activities are dominated by 
molecular size in such generalization.  
 
The activities and properties are related using the general 
mathematical function, F: Biological activity = f [structure 
(physicochemical descriptors as structural parameters)]. 
Biological activity is often defined as a measure of log 1/C, ki, 
IC₅₀, EC₅₀, log k and Km as described elsewhere [3-5]. The 
relationship is often not a mathematical expression derived by 
statistical or related techniques. The parameters describe 
structural and physiochemical properties as independent 
variables and the biological activities as dependent variable for 
usage in multiple linear regression (MLR) analysis. We describe 
the QSAR of 15 triazoles derivatives with relationship between 
structural and physiochemical parameters to known biological 
activity log IC50 values. 
 
 
Figure 1 (A): Parent structure of 1-[benzofuran-2-yl-(4-
alkyl/aryl-phenyl)-methyl]-1H-triazoles;  (B):  2D structure of 
R115866 model compound. 
 
Methodology: 
The physiochemical properties used in the study are molar 
refractivity, molar volume, parachor, index of refraction, 
surface tension and polarizibility to co-relate with biological 
activity (log IC50 inhibitory concentration). The physiochemical 
properties were estimated using Chemsketch 5.0 (from ACD 
Lab) and multiple linear regressions are done by SPSS Software 
[4, 6]. The physicochemical parameters used in the study are 
described below.  
 
Density (D):  
Density is a steric parameter calculated by ACD Lab Chem 
Sketch Software. This parameter is related to the bulk and size 
of the substituent. 
 
Molecular weight (MW):  
Molecular weight descriptor has been used as a descriptor in 
systems such as transport studies where diffusion is the mode 
of operation. It is an important variable in QSAR studies 
pertaining to cross resistance of various drugs in multi-drug 
resistant cell lines. 
 Molar refractivity (MR):  
Molar refractivity is generally considered to be a measure of 
overall bulkiness and is related to London dispersion forces 
using MR=4πNα/3; where N is Avogadro number and α is the 
polarizability of the molecule. It gives no information about 
shape and is generally scaled 0.1 and has been extensively used 
in QSAR. 
 
Parachor (Pc): 
This parameter is calculated by ACD Lab Chem Sketch 
Software (Chem Sketch). The Parachor may be defined as the 
molar volume of a liquid at a temperature at which its surface 
tension is unity. Parachor is obtained experimentally using Pc= 
(MW/d) γ ¼ where, Pc is a molar volume term that is corrected 
by surface tension (γ) rise to the power 1/4. 
 
Indicator variables:  
These are not QSAR parameters but are used to indicate the 
significance of any particular group or species at a particular 
substitution site in a given series of drugs. 
 
Discussion:  
QSAR was performed on a series of 15, 4-alkyl/aryl-substituted 
1-[benzofuran-2-yl-phenylmethyl]-1 H-triazoles derivatives 
with the physicochemical parameters (Table 3, see 
supplementary material), the biological activity (pIC50) is a 
measure of inhibitory activity indicators (Table 1, see 
supplementary material). We have used Hansch analysis [8] for 
developing these models. The QSAR multiple regression 
analyses were performed with SPSS (version 14.0) package. 
Their activity data and the physicochemical parameters 
evaluated in the correlation are listed in (Table 3, 
supplementary material). Linear regression analysis was 
performed on present series of triazoles derivaties according to 
physiochemical properties given in (Table  2, See 
supplementary material). These parameters were found to be 
useful in QSAR based drug modeling (please see 
supplementary material for modeling equations 1 to 7). The 
effect of substituent indicator parameters –I6 (CH2CH2CH2), + 
I₂₀ (CH-(CH2CH3)2) at R (see Figure 1a), IR2 position was 
studied (see Table 2, supplementary material) in equations 2 to 
7. 
 
Analysis through univariate correlation produced very low 
correlation coefficient (see equation 1 in supplementary 
material). Bivariate analysis gave a slightly improved value. 
Tetra and penta variate analysis results are encouraging with 
high correlation coefficient. The high value of F-test ratio and 
low value of standard error of estimation support reports 
described elsewhere [7, 8]. 
 
We estimated the log IC50 values with the observed ones (Table 
4, See supplementary material) for comparison. Such 
correlations are graphically represented in Figure 2. In bivariate 
analysis, correlation coefficient are little higher. However, it is 
not sufficient to describe the structure activity relationship in a 
quantitative manner. Correlation coefficients show best result 
obtained using St (surface tension), D (density), Pz 
(polarizability) with I6 (CH₂CH₂CH₃) and I20 (CH-
(CH2CH3)2). The mathematical model obtained from 
physiochemical properties are given in equations 5 to 7 (see 
supplementary material). Results are compared with observed BIOINFORMATION  open access 
 
ISSN 0973-2063 (online) 0973-8894 (print)     
Bioinformation 7(8):388-392 (2011)  390   © 2011 Biomedical Informatics
 
values of log IC50  (Table 4, See supplementary material). 
Substitution effects are shown using the indicator parameters. 
 
Equations suggest that the positive correlation coefficient of 
structural parameters D, St, IOR show a direct relationship with 
biological activity log IC50. Parameters like Pz have negative 
correlation coefficient with inverse relationship for biological 
activity log IC50. The positive sign for parameter D, St and IOR 
explains that as the bulkiness of the compound increases the 
potency of the drug likeliness to increase. The negative sign of 
the regression coefficient of Pz means less electronegative 
substituent for increased activity [9]. 
 
The equation 4 (supplementary material) suggests that the 
positive correlation coefficient of structural parameters Index of 
Refractivity (IOR) shows direct relationship with biological 
activity logIC50. The positive correlation coefficient of Indicator 
IR₂ for substituent 15 shows positive impact on the biological 
activity quantitatively. The negative (-ve) correlation coefficient 
of indicator IR CH₂CH₂CHз at position 3 show inverse 
relationship with biological activity. 
 
Predicted and residual values for the best model equation 4 are 
given in (Table 4,  See supplementary material). In this 
equation the F ratio value is much higher than the theoretical F 
value [F₃,  ₁₁=33.052] indicating the statistical significance of 
this model equation. Predicted values are the calculated 
activities from the equation and the residual values are the 
difference between the observed biological activities and the 
calculated activities. 
 
Conclusion: 
The study shows that the biological activity log IC₅₀ is structure 
specific in nature for a particular series of derivatives. Model 
equations suggest that the presence of CH₂CH₂CHз at R 
position show negative and substituent 15 at R₂ position have 
positive impact on the biological activity. Thus, compound 
R115866 shows the best correlation for further consideration. 
The name and molecular structure of compound is R115866 – 
N- [4-[2- ethyl – 1- (1H-1, 2, 4-triazol-1-yl) butyl] phenyl]-2-
benzothiazolamine (Figure 1b). 
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Supplementary material: 
 
Model Equations: 
Equation  Number Observations  Inference 
pIC₅₀= 14.057(±22.206) IOR- (18.189)  →  (1) 
n=15, r=0.335, r² = 0.126, RA² = -0.059, Se 
= 0.923806, F = 1.870.  poor 
pIC₅₀ = 5.651 (±8.896) IOR + 3.296 (±0.827)I₂₀ - (4.477)  →  (2) 
n=15, r=0.938, r² = 0.880, RA²= 0.860, Se= 
0.356466, F=43.936  better 
pIC₅₀ = 12.609 (±23.565) IOR -  (0.603) (±2.192)I₆ - (15.750)  →  (3) 
n=15, r=0.389, r² = 0.058, RA²= 0.010, Se= 
0.947465, F=1.068.  QSAR 
pIC₅₀ = 4.383(±8.757) IOR + 3.286 (±0.797)I₂₀ -(0.539)(±0.794) I₆ - (2.339)  →  (4) 
n=15, r=0.949, r² = 0.890, RA²= 0.860, Se= 
0.339419; F=33.052.  good 
pIC₅₀ = 3.443E-02 (±0.0604) St + 3.319 (±0.771)I₂₀- (0.543)(±0.777) I₆ + 3.271  →  (5) 
n=15, r=0.950, r² = 0.903, RA²= 0.877, Se= 
0.334404, F=34.161  good 
pIC₅₀ = 0.754 (±3.141) D + 3.364 (±0.809)I₂₀ (0.584)(±0.813) I₆ + 5.117  →  (6) 
n=15, r=0.944, r² = 0.892, RA²= 0.862, Se= 
0.353196, F=30.243  good 
pIC₅₀ = -1.69E-02 (±0.0641) Pz + 3.450 (±0.852)I₂₀- (0.663)(±0.819)I₆+5.607  →  (7) 
n=15, r=0.945, r² = 0.892, RA²= 0.863, Se= 
0.352333, F=30.409  good 
IOR = Index of Refraction; I = indicator parameters; n = number of data paint; r = Coefficient of regression; R²A = Explained Variance; r² = 
Coefficient of determination; Se= Standard error of estimation; F = Ratio of mean square for regression to mean square for residual.  
 
Table 1:  Biological activity, physiochemical and Indicator parameters of compounds 
S.No. R  R₁ R ₂  X Y pIC₅₀(μM)  IR  IR₂ 
1  CH₂CH₃  H 
O  
N CH  5.346787  0  0 
2  CH₂CH₃  H 
O  
CH  N  5.30103 0  0 
3  CH₂CH₂CH₃  H 
O  
N  CH  4.30103 0  0 
4  CH(CH₃)₂  H 
O  
N CH  4.69897  0  0 
5  CH(CH₃)₂  H 
O  
CH N  4.30103  0  0 
6  C(CH₃)₃  H 
O  
N  CH       5  1  0 
7  CH₂CH(CH₃)₂  H 
O
N CH  4.39794  0  0 
8 cyclohexyl H 
O
N CH  5.30103  0  0 
9  C₆H₅  H 
O  
N CH  5.154902  0  0 
10  C₆H₅  H 
O  
CH N  5.045757  0  0 
11  p-Cl-C₆H₅  H 
O  
N CH  4.69897  0  0 BIOINFORMATION  open access 
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Table 2:  Physicochemical parameters of 15 triazoles derivatives 
comp  Mol. weight  Molar 
refractivity 
Molecular 
volume 
Parachor  Index of 
Refraction 
Surface 
Tension 
density Polarizability 
1 303.357  91.18  250.2  654  1.649  46.6  46.6  36.14 
2 303.357  91.18  250.2  654  1.649  46.6  46.6  36.14 
3 317.384  95.79  266.2  692.6  1.638  45.7  45.7  37.97 
4 317.384  95.6  265.4  685.1  1.639  44.4  44.4  37.9 
5 317.384  95.6  265.4  685.1  1.639  44.4  44.4  37.9 
6 331.41  100.56  285.9  731.1  1.62  42.7  42.7  39.86 
7 331.41  100.21  281.4  723.7  1.63  43.7  43.7  39.72 
8 357.448  107.25  286.8  761.2  1.67  49.6  49.6  42.51 
9 351.4  107.25  286.8  761.2  1.67  49.6  49.6  42.51 
10 351.4  107.25  286.8  761.2  1.67  49.6  49.6  42.51 
11 385.845  111.85  296.1  790  1.679  50.6  50.6  44.34 
12 385.845  111.85  296.1  790  1.679  50.6  50.6  44.34 
13 531.437  138.58  379.6  1019.7  1.65  52  52  35.5 
14 308.76  88.41  226.1  613.7  1.709  53.9  53.9  35.05 
15 377.505  112.74  298.8  793.6  1.678  49.7  49.7  44.69 
 
Table 3: Auto–correlation Matrix demonstrating physicochemical parameters with indicators 
 MW  MR  MV  Pc  Ior  St  Density  Pz  I₆ I ₂₀ 
Activity  0.1108508 0.173446 0.090809 0.122906 0.35377  0.277093 0.16759  0.3319 -0.234 0.928 
MW  1  0.975411 0.951138 0.977554 0.13529  0.502336 0.6168282 0.155  -0.164 0.126 
MR   1  0.975435 0.993565 0.11925  0.452125 0.5079479 0.34  -0.173 0.198 
MV     1  0.991838 -0.10103 0.258493 0.350012  0.2563 -0.124 0.141 
Pc       1  0.02005  0.37907  0.4564434 0.2643 -0.141 0.153 
Ior         1  0.899101 0.7580828 0.3087 -0.232 0.234 
St        1  0.9198325 0.1731 -0.189 0.142 
Density         1 -0.016  -0.204  0.093 
P z            1 -0.148  0.393 
I₆             1 -0.071 
I₂₀               1 
 
Table 4:  Comparison between observed, predicted and their residual values 
Observed  values Predicted  values Residual  values 
5.34679   4.88437  0.46242 
5.30102   4.88437  0.41663 
4.301   4.301  0 
4.69897   4.83956  -0.14066 
4.30102   4.83956  -0.53854 
5   4.75442  0.24558 
4.39794   4.79923  -0.40129 
5.30102   4.97847  0.32255 
5.15490   4.97847  0.17643 
5.04575   4.97847  0.06653 
4.69897   5.0188 -0.3208 
4.69897   5.0188 -0.3208 
4.92081   4.88885  0.03115 
5.15490   5.15323  0.00077 
8.301   8.301  0 
 
12  p-Cl-C₆H₅  H 
O  
CH N  4.69897  0  0 
13    p-Cl-C₆H₅  Cl  O
O
O N N
O
 
CH CH  4.920819  0  0 
14    p-H-C₆H₅  H  N
H
N  
CH CH  5.154902  0  0 
15  N
S
NH p
   
H 
 
N CH  8.30193  0  1 